Status:
WITHDRAWN
Treatment of Endometrial Hyperplasia With an Intrauterine Device (IUD)
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborating Sponsors:
Center for Research on Women and Newborn Health
Conditions:
Endometrial Hyperplasia
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this research is to determine the effectiveness of the intrauterine device (IUD) called Mirena when compared to the Provera tablets used in treating this condition.
Detailed Description
Endometrial hyperplasia without atypia is a condition usually caused by excessive stimulation of the uterine lining (endometrium) by estrogens, and may cause irregular bleeding as a presenting symptom...
Eligibility Criteria
Inclusion
- Histologic diagnosis of simple or complex endometrial hyperplasia without atypia
- Normal pap smear within one year
Exclusion
- Diabetes
- Family history of endometrial cancer
- Contraindications for the intrauterine device
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00123175
Start Date
September 1 2009
End Date
September 1 2011
Last Update
January 8 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.